微泡
PI3K/AKT/mTOR通路
外体
间充质干细胞
小RNA
细胞生物学
蛋白激酶B
胰岛素样生长因子1受体
拮抗剂
生物发光成像
癌症研究
医学
化学
病理
信号转导
生物
转染
细胞培养
内科学
生长因子
受体
荧光素酶
基因
生物化学
遗传学
作者
Yifan Tang,Yanqing Sun,Junkai Zeng,Bo Yuan,Yin Zhao,Xiongsheng Chen,Lianshun Jia,Shengyuan Zhou,Xiongsheng Chen
出处
期刊:Research Square - Research Square
日期:2022-06-01
标识
DOI:10.21203/rs.3.rs-1669995/v1
摘要
Abstract Background Ossification of the posterior longitudinal ligament (OPLL) is a disabling disease, of which the pathogenesis is still unclear, and there are no effective cure or prevention methods. Exosomal miRNA play an important role in osteogenesis of the ectopic bone. Therefore, we focused on the down-regulation miR-140-5p from OPLL cell-derived exosomes in order to explore the mechanism of exosomal miR-140-5p in inhibiting osteogenesis in OPLL. Results Exosomes were isolated by differential centrifugation and identified by transmission electron microscopy, nanoparticle tracking analysis, and exosomal markers. Exosomal RNA was extracted to perform miRNA sequencing and disclose the differentially expressed miRNAs, among which miR-140-5p was significantly down-regulated. The confocal microscopy was used to trace the exosomal miR-140-5p delivered from OPLL cells to human mesenchymal stem cells (hMSCs). In vitro, we verified exosomal miR-140-5p inhibited osteoblast differentiation of hMSCs by targeting IGF1R and suppressing the phosphorylation of IRS1/PI3K/Akt/mTOR pathway. In vivo, we verified that exosomal miR-140-5p inhibited the ectopic bone formation in mice assessed by micro-CT and immunohistochemistry. Conclusions We found that exosomal miR-140-5p could inhibit the osteogenic differentiation of hMSCs by targeting IGF1R and regulating the mTOR pathway, prompting a further potential means of drug treatment and a possible target for molecular therapy of OPLL.
科研通智能强力驱动
Strongly Powered by AbleSci AI